Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies

Clinical trial NCT00703625 · COMPLETED

Trial details

NCT number: NCT00703625
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Resistant Solid Malignancies

Start date: 2008-03-08
Primary completion: 2011-05-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.